Press Release: BioXcel : BioXcel Therapeutics to Present Data on [BXCL701] at the 24th Annual Prostate Cancer Foundation Scientific Retreat

BRANFORD, Conn., Oct. 05, 2017 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, a biopharmaceutical company committed to developing novel drugs targeting immuno-oncology and neurological and psychiatric diseases, today announced the presentation of new data supporting the Company's lead immuno-oncology product candidate, [BXCL701], at the 24th Annual Prostate Cancer Foundation Scientific Retreat, being held October 5-7, in Washington, DC.